These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30941659)

  • 1. A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.
    Fahr P; Buchanan J; Wordsworth S
    Appl Health Econ Health Policy; 2019 Aug; 17(4):443-452. PubMed ID: 30941659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.
    Phillips KA; Douglas MP; Trosman JR; Marshall DA
    Value Health; 2017 Jan; 20(1):47-53. PubMed ID: 28212968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economic evaluation in orthotics and prosthetics: a systematic review protocol.
    Clarke L; Dillon M; Shiell A
    Syst Rev; 2019 Jun; 8(1):152. PubMed ID: 31248460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
    Phillips KA; Deverka PA; Marshall DA; Wordsworth S; Regier DA; Christensen KD; Buchanan J
    Value Health; 2018 Sep; 21(9):1033-1042. PubMed ID: 30224106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?
    Husereau D; Marshall DA; Levy AR; Peacock S; Hoch JS
    Int J Technol Assess Health Care; 2014 Apr; 30(2):179-87. PubMed ID: 24806420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group.
    Chan KKW; Cheung MC; Regier DA; Hay A; Louie AV; Cheung WY; Tarride JE; Udayakumar S; Mittmann N
    Curr Oncol; 2021 Sep; 28(5):3649-3658. PubMed ID: 34590616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage With Evidence Development and Managed Entry in the Funding of Personalized Medicine: Practical and Ethical Challenges for Oncology.
    Lewis JR; Kerridge I; Lipworth W
    J Clin Oncol; 2015 Dec; 33(34):4112-7. PubMed ID: 26460298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.
    Wordsworth S; Doble B; Payne K; Buchanan J; Marshall DA; McCabe C; Regier DA
    Value Health; 2018 Sep; 21(9):1048-1053. PubMed ID: 30224108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues surrounding the health economic evaluation of genomic technologies.
    Buchanan J; Wordsworth S; Schuh A
    Pharmacogenomics; 2013 Nov; 14(15):1833-47. PubMed ID: 24236483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review.
    Wright SJ; Newman WG; Payne K
    Pharmacoeconomics; 2019 Aug; 37(8):1011-1027. PubMed ID: 31087278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big data hurdles in precision medicine and precision public health.
    Prosperi M; Min JS; Bian J; Modave F
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):139. PubMed ID: 30594159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.
    Fahr P; Buchanan J; Wordsworth S
    Pharmacoeconomics; 2020 Feb; 38(2):143-158. PubMed ID: 31741314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied.
    Luhnen M; Prediger B; Neugebauer EAM; Mathes T
    Syst Rev; 2017 Dec; 6(1):238. PubMed ID: 29197411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of genomic/genetic tests: a review and future directions.
    Bouttell J; Heggie R; Oien K; Romaniuk A; VanSteenhouse H; von Delft S; Hawkins N
    Int J Technol Assess Health Care; 2022 Aug; 38(1):e67. PubMed ID: 36317681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for health technologies: specific guidance for oncology products in Canada.
    Mittmann N; Evans WK; Rocchi A; Longo CJ; Au HJ; Husereau D; Leighl NB; Isogai PK; Krahn MD; Peacock S; Marshall D; Coyle D; Taylor SC; Jacobs P; Oh PI
    Value Health; 2012 May; 15(3):580-5. PubMed ID: 22583470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARDIOVASCULAR SCREENING OF YOUNG ATHLETES: A REVIEW OF ECONOMIC EVALUATIONS.
    Gerkens S; Van Brabandt H; Desomer A; Leonard C; Neyt M
    Int J Technol Assess Health Care; 2017 Jan; 33(1):76-83. PubMed ID: 28436336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of quality-adjusted life-years in the economic evaluation of health technologies in Spain: a review of the 1990-2009 literature.
    Rodriguez JM; Paz S; Lizan L; Gonzalez P
    Value Health; 2011 Jun; 14(4):458-64. PubMed ID: 21669370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.
    Marshall DA; Grazziotin LR; Regier DA; Wordsworth S; Buchanan J; Phillips K; Ijzerman M
    Value Health; 2020 May; 23(5):566-573. PubMed ID: 32389221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.